Your browser doesn't support javascript.
loading
Delay in antibiotic therapy results in fatal disease outcome in murine pneumococcal pneumonia.
Berger, Sarah; Goekeri, Cengiz; Gupta, Shishir K; Vera, Julio; Dietert, Kristina; Behrendt, Ulrike; Lienau, Jasmin; Wienhold, Sandra-Maria; Gruber, Achim D; Suttorp, Norbert; Witzenrath, Martin; Nouailles, Geraldine.
Afiliação
  • Berger S; Division of Pulmonary Inflammation, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
  • Goekeri C; Division of Pulmonary Inflammation, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
  • Gupta SK; Department of Dermatology, Laboratory of Systems Tumor Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Vera J; Department of Dermatology, Laboratory of Systems Tumor Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Dietert K; Department of Veterinary Pathology, Freie Universität Berlin, Berlin, Germany.
  • Behrendt U; Division of Pulmonary Inflammation, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
  • Lienau J; Division of Pulmonary Inflammation, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
  • Wienhold SM; Division of Pulmonary Inflammation, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
  • Gruber AD; Department of Veterinary Pathology, Freie Universität Berlin, Berlin, Germany.
  • Suttorp N; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Witzenrath M; Division of Pulmonary Inflammation, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany. martin.witzenrath@charite.de.
  • Nouailles G; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. martin.witzenrath@charite.de.
Crit Care ; 22(1): 287, 2018 Nov 01.
Article em En | MEDLINE | ID: mdl-30382866
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Pneumocócica / Fatores de Tempo / Antibacterianos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Crit Care Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Pneumocócica / Fatores de Tempo / Antibacterianos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Crit Care Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha